Clinical trial NCT00000514 - References

Hypertension — Systolic Hypertension in the Elderly Program (SHEP)

Citation(s)

•   Applegate WB, Davis BR, Black HR, Smith WM, Miller ST, Burlando AJ
  Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc. 1991 Nov;39(11):1057-64.
•   Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM Jr, et al
  Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994 Oct 10;154(19):2154-60.
•   Applegate WB
  Quality of life during antihypertensive treatment. Lessons from the Systolic Hypertension in the Elderly Program. Am J Hypertens. 1998 Mar;11(3 Pt 2):57S-61S. Review.
•   Bearden D, Allman R, McDonald R, Miller S, Pressel S, Petrovitch H
  Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc. 1994 Nov;42(11):1143-9.
•   Black HR, Unger D, Burlando A, Wright JC, Pressel SL, Allen R, McDonald RH, Surath H
  Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings. Hypertension. 1991 Mar;17(3 Suppl):II77-101.
•   Borhani NO, Applegate WB, Cutler JA, Davis BR, Furberg CD, Lakatos E, Page L, Perry HM, Smith WM, Probstfield JL
  Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension. 1991 Mar;17(3 Suppl):II2-15.
•   Borhani NO
  Risk management in stroke prevention: major clinical trials in hypertension. Health Rep. 1994;6(1):76-86. Review. English, French.
•   Cosgrove N, Borhani NO, Bailey G, Borhani P, Levin J, Hoffmeier M, Krieger S, Lovato LC, Petrovitch H, Vogt T, Wilson AC, Breeson V, Probstfield JL
  Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research Group. Control Clin Trials. 1999 Apr;20(2):133-48.
•   Curb JD, Lee M, Jensen J, Applegate W
  Systolic Hypertension in the Elderly Program (SHEP). Part 4: Baseline medical history findings. Hypertension. 1991 Mar;17(3 Suppl):II35-61.
•   Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J
  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA. 1996 Dec 18;276(23):1886-92. Erratum in: JAMA 1997 May 7;277(17):1356.
•   Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J
  Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Stroke. 1998 Jul;29(7):1333-40.
•   Davis BR, Wittes J, Pressel S, Berge KG, Hawkins CM, Lakatos E, Moyé LA, Probstfield JL
  Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP). Control Clin Trials. 1993 Oct;14(5):350-61.
•   Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J
  Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation. 1996 Nov 15;94(10):2381-8.
•   Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J
  Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program. Circulation. 1996 Jul 1;94(1):26-34.
•   Furberg CD, Cutler JA, Probstfield JL, et al: The Systolic Hypertension in the Elderly Program
  Mild Hypertension: From Drug Trials to Practice, Raven Press, New York, 59-63, 1987.
•   Hall WD, Davis BR, Frost P, Hoffmeier M, O'Brien JE, Pace S, Page L, Schneider KA, Stamler J
  Systolic Hypertension in the Elderly Program (SHEP). Part 7: Baseline laboratory characteristics. Hypertension. 1991 Mar;17(3 Suppl):II102-22.
•   Hertert S, Bailey G, Cottinghan V, Carmody S, Egan D, Johnson P, Probstfield J
  Community volunteers as recruitment staff in a clinical trial: the systolic hypertension in the elderly program (SHEP) experience. Control Clin Trials. 1996 Feb;17(1):23-32. Erratum in: Control Clin Trials 1996 Jun;17(3):271.
•   Hulley SB, Feigal D, Ireland C, Kuller LH, Smith WM
  Systolic hypertension in the elderly program (SHEP). The first three months. J Am Geriatr Soc. 1986 Feb;34(2):101-5.
•   Implications of the systolic hypertension in the elderly program
  The Systolic Hypertension in the Elderly Program Cooperative Research Group. Hypertension. 1993 Mar;21(3):335-43.
•   Kostis JB, Allen R, Berkson DM, Curb JD, Davey J, Grimm RH, Hall WD, Lacy CR, Lee M, Miller S, et al
  Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group. Am Heart J. 1994 Jan;127(1):112-21.
•   Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB
  Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA. 1997 Jul 16;278(3):212-6.
•   Kostis JB, Lacy CR, Hall WD, Wilson AC, Borhani NO, Krieger SD, Cosgrove NM
  The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group. Am J Cardiol. 1994 Sep 1;74(5):464-7.
•   Kostis JB, Lawrence-Nelson J, Ranjan R, Wilson AC, Kostis WJ, Lacy CR
  Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens. 2001 Aug;14(8 Pt 1):798-803.
•   Kostis JB, Prineas R, Curb JD, Lee M, Berkson D, Raines J, Frishman W, Francis CK, Sheffield T
  Systolic Hypertension in the Elderly Program (SHEP). Part 8: Electrocardiographic characteristics. Hypertension. 1991 Mar;17(3 Suppl):II123-51.
•   Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR; SHEP Collaborative Research Group
  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2005 Jan 1;95(1):29-35.
•   Labarthe DR, Blaufox MD, Smith WM, Lacy CR, Schnaper H, LaBaw F, Mascioli S, Davey J, Lakatos E
  Systolic Hypertension in the Elderly Program (SHEP). Part 5: Baseline blood pressure and pulse rate measurements. Hypertension. 1991 Mar;17(3 Suppl):II62-76.
•   Moyé LA, Davis BR, Hawkins CM, Probstfield JL
  Conclusions and implications of the systolic hypertension in the elderly program. Clin Exp Hypertens. 1993 Nov;15(6):911-24.
•   Pahor M, Shorr RI, Somes GW, Cushman WC, Ferrucci L, Bailey JE, Elam JT, Applegate WB
  Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med. 1998 Jun 22;158(12):1340-5.
•   Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovitz AJ
  Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol. 1991 Feb;17(2):422-30.
•   Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL
  Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000 Jul 26;284(4):465-71.
•   Petrovitch H, Byington R, Bailey G, Borhani P, Carmody S, Goodwin L, Harrington J, Johnson HA, Johnson P, Jones M, et al
  Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment. Hypertension. 1991 Mar;17(3 Suppl):II16-23.
•   Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
  Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991 Jun 26;265(24):3255-64.
•   Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB, et al
  The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Clin Exp Hypertens A. 1989;11(5-6):973-89.
•   Probstfield JL, Applegate WB, Curb JD, et al for the SHEP Cooperative Research Group: The Systolic Hypertension in the Elderly Program (SHEP): Rationale, Design, Recruitment, and Baseline Data
  In: Omae T, Zanchetti A, (Eds.) How Should Elderly Hypertensive Patients Be Treated? Tokyo: Springer-Verlag, 135-142, 1989.
•   Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension
  The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. J Clin Epidemiol. 1988;41(12):1197-208.
•   Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J
  Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998 Apr 13;158(7):741-51.
•   Schron EB, Davey JA, Jensen JM, Probstfield JL
  The systolic hypertension in the elderly program. Implications for nursing practice and research. Prog Cardiovasc Nurs. 1989 Oct-Dec;4(4):138-45.
•   Staessen JA, Amery A, Birkenhäger W
  Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension. Hypertension. 1994 Feb;23(2):269-70.
•   Systolic Hypertension in the Elderly Program (SHEP)
  Baseline Characteristics of the Randomized Participants. Black HR, Curb JD, Pressel S, et al, Guest Editors.
•   Vogt TM, Schron E, Pressel S, Wasserthiel-Smoller S, Eddleman EE, Miller S, Stamler J
  Systolic Hypertension in the Elderly Program (SHEP). Part 3: Sociodemographic characteristics. Hypertension. 1991 Mar;17(3 Suppl):II24-34.
•   Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, Kostis J, Pressel S, Schron E
  Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med. 1996 Mar 11;156(5):553-61.
•   Wassertheil-Smoller S, Fann C, Allman RM, Black HR, Camel GH, Davis B, Masaki K, Pressel S, Prineas RJ, Stamler J, Vogt TM
  Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med. 2000 Feb 28;160(4):494-500.
•   Weiler PG, Camel GH, Chiappini M, Greenlick MR, Hughes GH, Luhr JC, Moyé LA, Mungas D, Perron M, Peters MH, et al
  Systolic Hypertension of the Elderly Program (SHEP). Part 9: Behavioral characteristics. Hypertension. 1991 Mar;17(3 Suppl):II152-61.
•   Winker MA, Murphy MB
  Isolated systolic hypertension in the elderly. JAMA. 1991 Jun 26;265(24):3301-2.
•   Wittes J, Davis B, Berge K, Cohen JD, Grimm RH Jr, Hawkins CM, Kuller L
  Systolic Hypertension of the Elderly Program (SHEP). Part 10: Analysis. Hypertension. 1991 Mar;17(3 Suppl):II162-7.
•   Wittes J, Lakatos E, Black D, Geraci B, Davis B, Moyé L, Probstfield J
  Selecting screening criteria for clinical trials: an example from the Systolic Hypertension in the Elderly Program. Control Clin Trials. 1999 Apr;20(2):121-32.

Details for clinical trial NCT00000514